torbafylline has been researched along with Burns in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balasubramaniam, A; Friend, LA; James, JH; Joshi, R; Kadeer, N; Sheriff, S | 1 |
1 other study(ies) available for torbafylline and Burns
Article | Year |
---|---|
Phosphodiesterase (PDE) inhibitor torbafylline (HWA 448) attenuates burn-induced rat skeletal muscle proteolysis through the PDE4/cAMP/EPAC/PI3K/Akt pathway.
Topics: Animals; Burns; Cyclic Nucleotide Phosphodiesterases, Type 4; Male; Models, Biological; Muscle, Skeletal; Pentoxifylline; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Proteolysis; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2014 |